Medical News
- dermatologytimes.com04/19/2024
- medicalxpress.com04/19/2024
- insideprecisionmedicine.com04/19/2024
Popular
- Project Oncology®
Personalizing Relapsed/Refractory CLL Care: Key Factors to Consider
Charles Turck, PharmD, BCPS, BCCCP
Lindsey Roeker, MD
Matthew Lunning, DO, FACP
- Project Oncology®
Best Practices for Utilizing Shared Decision-Making in CLL Care
Charles Turck, PharmD, BCPS, BCCCP
Adam Kittai, MD
- Project Oncology®
Managing B-Cell Lymphomas in the Second-Line Setting: The Role of CAR T-Cell Therapy
Jennifer Caudle, DO
Sarah Rutherford, MD
Charles Turck, PharmD, BCPS, BCCCP
Seema A. Bhat, MD
Joanna Rhodes, MD, MSCE
Charles Turck, PharmD, BCPS, BCCCP
Richard R. Furman, MD
Javier Pinilla, MD, PhD
CME/CE
David J. Kuter, MD, DPhil
Spero R. Cataland, MD
Catherine Broome, MD
Cindy Neunert, MD, MSCS
Caitlin Costello, MD
Sagar Lonial, MD, FACP
Sagar Lonial, MD, FACP
Alexander Drilon, MD
Clinical Practice
- Project Oncology®
The CLL Landscape: A Look at Current and Future Therapies
John Russell, MD
Andrew H. Lipsky, MD
Charles Turck, PharmD, BCPS, BCCCP
Adam Kittai, MD
- Project Oncology®
Navigating CLL Treatment: A Deep Dive into Efficacy and Safety
John Russell, MD
Seema A. Bhat, MD
- Project Oncology®
Monitoring Treatment Reponses in CLL: A Review of Key Protocols
Charles Turck, PharmD, BCPS, BCCCP
Lindsey Roeker, MD
Programs
- Project Oncology®
CLL Treatment: Managing Uncertainty Through Effective Communication
John C. Byrd, MD
- Project Oncology®
AEGEAN Trial: The Role of Perioperative Durvalumab in NSCLC
- Project Oncology®
Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights
Alan Bryce, MD
Charu Aggarwal, MD, MPH